Inebilizumab - CaLiGraph

CaLiGraph

Property	Value
rdf:type	Antineoplastic drug owl:NamedIndividual Monoclonal antibody Orphan drug Therapeutic monoclonal antibody Drug granted breakthrough therapy designation
rdfs:label	Inebilizumab
owl:sameAs	dbr:Inebilizumab
prov:wasDerivedFrom	http://en.wikipedia.org/wiki/Category:Orphan_drugs http://en.wikipedia.org/wiki/List_of_therapeutic_monoclonal_antibodies http://en.wikipedia.org/wiki/Category:Antineoplastic_drugs http://en.wikipedia.org/wiki/Category:Monoclonal_antibodies http://en.wikipedia.org/wiki/List_of_drugs_granted_breakthrough_therapy_designation http://en.wikipedia.org/wiki/Neuromyelitis_optica_spectrum_disorder
skos:prefLabel	Inebilizumab
skos:altLabel	inebilizumab
clgo:alternativeName	Uplizna
clgo:casNumber	1299440-37-1
clgo:class	Chemotherapy
clgo:drugbank	DB12530
clgo:fdaUniiCode	74T7185BMM
clgo:kegg	D11757

About: clgr:Inebilizumab